| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/17/2014 | WO2014110248A1 Controlled release formulations of lorazepam |
| 07/17/2014 | WO2014110245A1 Sustained release formulations of lorazepam |
| 07/17/2014 | WO2014110225A1 Hmgb1-binding beads and uses thereof |
| 07/17/2014 | WO2014108687A1 Dynamic suspension drying (dsd) to control ostwald ripening |
| 07/17/2014 | WO2014108685A1 Pharmaceutical compositions |
| 07/17/2014 | WO2014108574A1 Solid solution compositions and use in severe pain |
| 07/17/2014 | WO2014108573A1 Solid solution compositions and use in chronic inflammation |
| 07/17/2014 | WO2014108572A1 Solid solution compositions and use in cardiovascular disease |
| 07/17/2014 | WO2014108569A1 Compositions and methods for treating severe pain |
| 07/17/2014 | US20140200654 Drug-delivery endovascular stent and method of forming the same |
| 07/17/2014 | US20140200531 Mixture for transdermal delivery of low and high molecular weight compounds |
| 07/17/2014 | US20140200530 Transdermal estrogen device and delivery |
| 07/17/2014 | US20140200516 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 07/17/2014 | US20140200276 Novel formulation of naproxen |
| 07/17/2014 | US20140200272 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/17/2014 | US20140200268 Composition and Method for Treating Dry Eye Syndrome |
| 07/17/2014 | US20140200237 Compositions of (-)-17-(Cyclobutylmethyl) Morphinan-3,14-Diol |
| 07/17/2014 | US20140200236 Opioid agonist/antagonist combinations |
| 07/17/2014 | US20140200196 Hydrogel Tattoo Protection and Aftercare System |
| 07/17/2014 | US20140199469 Sustained-release tablet and process for preparing the same |
| 07/17/2014 | US20140199406 Coating Composition, Drug-Containing Particle, Solid Preparation and Method for Preparing Drug-Containing Particle |
| 07/17/2014 | US20140199405 Method for treating cancer based on mutation status of k-ras |
| 07/17/2014 | US20140199401 Extended release pharmaceutical compositions of fesoterodine |
| 07/17/2014 | US20140199400 Active Agent Loaded Uniform, Rigid, Spherical, Nanoporous Calcium Phosphate Particles and Methods of Making and Using the Same |
| 07/17/2014 | US20140199398 High capacity diektopiperazine microparticles and methods |
| 07/17/2014 | US20140199397 Benzoyl Peroxide Microparticle Process |
| 07/17/2014 | US20140199395 Novel formulation of meloxicam |
| 07/17/2014 | US20140199394 Controlled release hydrocodone |
| 07/17/2014 | US20140199393 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/17/2014 | US20140199392 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/17/2014 | US20140199390 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/17/2014 | US20140199389 Enteric active substance delivery |
| 07/17/2014 | US20140199388 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/17/2014 | US20140199387 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/17/2014 | US20140199386 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/17/2014 | US20140199385 Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds |
| 07/17/2014 | US20140199384 Facile Route to the Synthesis of Resorcinarene Nanocapsules |
| 07/17/2014 | US20140199383 Abuse resistant opioid containing transdermal systems |
| 07/17/2014 | US20140199381 Core-shell microspheres |
| 07/17/2014 | US20140199377 Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| 07/17/2014 | US20140199375 Combination therapy for skin disorders |
| 07/17/2014 | US20140199374 Methods for preparation of lipid-encapsulated therapeutic agents |
| 07/17/2014 | US20140199373 Novel Formulations and Methods for Treating Dermatological Disorders or Diseases |
| 07/17/2014 | US20140199372 Microbial growth factors |
| 07/17/2014 | US20140199370 Cyclodextrin-based materials compositions and uses related thereto |
| 07/17/2014 | US20140199366 Sustained release intraocular implants and methods for treating ocular neuropathies |
| 07/17/2014 | US20140199364 Drug loaded fibers |
| 07/17/2014 | US20140199362 Clonidine compounds in a biodegradable fiber |
| 07/17/2014 | US20140199350 Chimeric topical vaccine for haemophilus influenzae-induced disease |
| 07/17/2014 | US20140199349 Ph-sensitive hyaluronic acid derivative and uses thereof |
| 07/17/2014 | US20140199296 Cancer Drug and Uses |
| 07/17/2014 | US20140199288 Pharmaceutical compositions containing botulinum neurotoxin |
| 07/17/2014 | US20140199282 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/17/2014 | US20140199266 Honey nasal rinse |
| 07/17/2014 | US20140199241 Liposomes comprising polymer-conjugated lipids and related uses |
| 07/17/2014 | US20140199233 Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor |
| 07/16/2014 | EP2754682A1 Method for manufacturing block copolymer |
| 07/16/2014 | EP2754670A1 Blood-brain barrier permeable peptide compositions |
| 07/16/2014 | EP2754463A2 Expandable devices |
| 07/16/2014 | EP2754454A2 Non-steroidal anti-inflammatory drug derivatives |
| 07/16/2014 | EP2754438A1 Coating composition, drug-containing particle, solid preparation and method for preparing drug-containing particle |
| 07/16/2014 | EP2754437A2 Stable digestive enzyme compositions |
| 07/16/2014 | EP2754436A1 Biodegradable high-efficiency dengue vaccine, method for making the same, and pharmaceutical composition comprising the same |
| 07/16/2014 | EP2754435A1 Biodegradable carrier with adjustable zeta potentials and particle sizes, method for making the same, and pharmaceutical composition comprising the same |
| 07/16/2014 | EP2753929A1 Cellular uptake control systems |
| 07/16/2014 | EP2753647A1 Hyaluronic acid/collagen- based dermal filler compositions and methods for making same |
| 07/16/2014 | EP2753362A1 Materials and methods for modulating immune responses |
| 07/16/2014 | EP2753350A1 Oral delivery for hemoglobin based oxygen carriers |
| 07/16/2014 | EP2753340A1 Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof |
| 07/16/2014 | EP2753323A1 Treating cough and tussive attacks |
| 07/16/2014 | EP2753314A1 Compositions of efavirenz |
| 07/16/2014 | EP2753313A1 Pharmaceutical compositions comprising an aromatase inhibitor |
| 07/16/2014 | EP2753312A1 Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases |
| 07/16/2014 | EP2753311A1 Antioxidant formulations |
| 07/16/2014 | EP2753310A2 Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
| 07/16/2014 | EP2753309A1 Pharmaceutical composition for oral administration with a statin |
| 07/16/2014 | EP2753308A1 Compositions of lopinavir and ritonavir |
| 07/16/2014 | EP2753307A1 Compositions of lopinavir |
| 07/16/2014 | EP2753306A1 Solid dosage forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate |
| 07/16/2014 | EP2753305A1 Coated suppositories |
| 07/16/2014 | EP2753304A1 Oral suspension |
| 07/16/2014 | EP2753303A1 Silicone coated implants |
| 07/16/2014 | EP2753302A1 Pharmaceutical invention of tapentadol |
| 07/16/2014 | CN203710401U 一种双突出双层肠道栓 A two prominent double-intestinal bolt |
| 07/16/2014 | CN203710400U 一种双突出肠道栓 A dual bolt protruding gut |
| 07/16/2014 | CN203710399U 一种带有复合层的中空鼻栓 A hollow nose plug having a composite layer |
| 07/16/2014 | CN203710398U 一种具有部分椭圆头锥中间和尾部突出的肠道栓 Having a portion of the intermediate oval head and tail cone bolt protruding gut |
| 07/16/2014 | CN203710397U 一种具有椭圆头锥的双层肠道栓 Intestinal double bolt head having an elliptical cone |
| 07/16/2014 | CN203710396U 一种不易脱出的肠道栓剂 One kind of difficult bowel prolapse suppository |
| 07/16/2014 | CN103930137A 卟啉-磷脂结合物微泡及其作为造影剂的用途 Porphyrin - phospholipid conjugate microbubbles and its use as a contrast agent |
| 07/16/2014 | CN103930119A 顺势疗法的治疗方法及其组合物 Homeopathic treatments, and combinations thereof |
| 07/16/2014 | CN103930115A 药物纳米粒组合物 Pharmaceutical compositions of nanoparticles |
| 07/16/2014 | CN103930110A 吡咯并喹啉基-吡咯烷-2,5-二酮制剂及制备和使用所述制剂的方法 Pyrrolo-quinoline group - pyrrolidine-2,5-dione and its preparation method and use of the formulation of the preparation |
| 07/16/2014 | CN103930107A 青蒿氧烷和哌喹的稳定剂型 Artemisia annua siloxane and piperaquine stable dosage forms |
| 07/16/2014 | CN103930106A 中枢神经变性疾病的改善和/或治疗用组合物 Degenerative diseases of the central nervous system to improve and / or therapeutic composition |
| 07/16/2014 | CN103930102A 含水贴剂 Aqueous patch |
| 07/16/2014 | CN103930098A 含有芬太尼及其同族体的经皮吸收制剂 Containing fentanyl and its congeners percutaneous absorption preparation |
| 07/16/2014 | CN103930097A 用于生产原位形成的基质的喷射体系 Injection system for the production of in-situ formed matrix |
| 07/16/2014 | CN103930096A 用于治疗糖尿病的制剂 Formulations for the treatment of diabetes |
| 07/16/2014 | CN103930095A 用于肺部给药的低共熔混合物 For pulmonary administration of low eutectic mixture |